Global Recombinant Hepatitis B Vaccine Market Growth 2023-2028

Report ID: 1271029 | Published Date: Jan 2025 | No. of Page: 103 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Recombinant Hepatitis B Vaccine Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Recombinant Hepatitis B Vaccine by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Recombinant Hepatitis B Vaccine by Country/Region, 2017, 2022 & 2028
    2.2 Recombinant Hepatitis B Vaccine Segment by Type
        2.2.1 10mcg/ml
        2.2.2 10mcg/0.5ml
    2.3 Recombinant Hepatitis B Vaccine Sales by Type
        2.3.1 Global Recombinant Hepatitis B Vaccine Sales Market Share by Type (2017-2022)
        2.3.2 Global Recombinant Hepatitis B Vaccine Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Recombinant Hepatitis B Vaccine Sale Price by Type (2017-2022)
    2.4 Recombinant Hepatitis B Vaccine Segment by Application
        2.4.1 Newborn
        2.4.2 Primary School Students
        2.4.3 Adult
    2.5 Recombinant Hepatitis B Vaccine Sales by Application
        2.5.1 Global Recombinant Hepatitis B Vaccine Sale Market Share by Application (2017-2022)
        2.5.2 Global Recombinant Hepatitis B Vaccine Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Recombinant Hepatitis B Vaccine Sale Price by Application (2017-2022)
3 Global Recombinant Hepatitis B Vaccine by Company
    3.1 Global Recombinant Hepatitis B Vaccine Breakdown Data by Company
        3.1.1 Global Recombinant Hepatitis B Vaccine Annual Sales by Company (2020-2022)
        3.1.2 Global Recombinant Hepatitis B Vaccine Sales Market Share by Company (2020-2022)
    3.2 Global Recombinant Hepatitis B Vaccine Annual Revenue by Company (2020-2022)
        3.2.1 Global Recombinant Hepatitis B Vaccine Revenue by Company (2020-2022)
        3.2.2 Global Recombinant Hepatitis B Vaccine Revenue Market Share by Company (2020-2022)
    3.3 Global Recombinant Hepatitis B Vaccine Sale Price by Company
    3.4 Key Manufacturers Recombinant Hepatitis B Vaccine Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Recombinant Hepatitis B Vaccine Product Location Distribution
        3.4.2 Players Recombinant Hepatitis B Vaccine Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Recombinant Hepatitis B Vaccine by Geographic Region
    4.1 World Historic Recombinant Hepatitis B Vaccine Market Size by Geographic Region (2017-2022)
        4.1.1 Global Recombinant Hepatitis B Vaccine Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Recombinant Hepatitis B Vaccine Annual Revenue by Geographic Region
    4.2 World Historic Recombinant Hepatitis B Vaccine Market Size by Country/Region (2017-2022)
        4.2.1 Global Recombinant Hepatitis B Vaccine Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Recombinant Hepatitis B Vaccine Annual Revenue by Country/Region
    4.3 Americas Recombinant Hepatitis B Vaccine Sales Growth
    4.4 APAC Recombinant Hepatitis B Vaccine Sales Growth
    4.5 Europe Recombinant Hepatitis B Vaccine Sales Growth
    4.6 Middle East & Africa Recombinant Hepatitis B Vaccine Sales Growth
5 Americas
    5.1 Americas Recombinant Hepatitis B Vaccine Sales by Country
        5.1.1 Americas Recombinant Hepatitis B Vaccine Sales by Country (2017-2022)
        5.1.2 Americas Recombinant Hepatitis B Vaccine Revenue by Country (2017-2022)
    5.2 Americas Recombinant Hepatitis B Vaccine Sales by Type
    5.3 Americas Recombinant Hepatitis B Vaccine Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Recombinant Hepatitis B Vaccine Sales by Region
        6.1.1 APAC Recombinant Hepatitis B Vaccine Sales by Region (2017-2022)
        6.1.2 APAC Recombinant Hepatitis B Vaccine Revenue by Region (2017-2022)
    6.2 APAC Recombinant Hepatitis B Vaccine Sales by Type
    6.3 APAC Recombinant Hepatitis B Vaccine Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Recombinant Hepatitis B Vaccine by Country
        7.1.1 Europe Recombinant Hepatitis B Vaccine Sales by Country (2017-2022)
        7.1.2 Europe Recombinant Hepatitis B Vaccine Revenue by Country (2017-2022)
    7.2 Europe Recombinant Hepatitis B Vaccine Sales by Type
    7.3 Europe Recombinant Hepatitis B Vaccine Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Recombinant Hepatitis B Vaccine by Country
        8.1.1 Middle East & Africa Recombinant Hepatitis B Vaccine Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Recombinant Hepatitis B Vaccine Revenue by Country (2017-2022)
    8.2 Middle East & Africa Recombinant Hepatitis B Vaccine Sales by Type
    8.3 Middle East & Africa Recombinant Hepatitis B Vaccine Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Recombinant Hepatitis B Vaccine
    10.3 Manufacturing Process Analysis of Recombinant Hepatitis B Vaccine
    10.4 Industry Chain Structure of Recombinant Hepatitis B Vaccine
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Recombinant Hepatitis B Vaccine Distributors
    11.3 Recombinant Hepatitis B Vaccine Customer
12 World Forecast Review for Recombinant Hepatitis B Vaccine by Geographic Region
    12.1 Global Recombinant Hepatitis B Vaccine Market Size Forecast by Region
        12.1.1 Global Recombinant Hepatitis B Vaccine Forecast by Region (2023-2028)
        12.1.2 Global Recombinant Hepatitis B Vaccine Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Recombinant Hepatitis B Vaccine Forecast by Type
    12.7 Global Recombinant Hepatitis B Vaccine Forecast by Application
13 Key Players Analysis
    13.1 Merck
        13.1.1 Merck Company Information
        13.1.2 Merck Recombinant Hepatitis B Vaccine Product Offered
        13.1.3 Merck Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Merck Main Business Overview
        13.1.5 Merck Latest Developments
    13.2 GlaxoSmithKline Plc
        13.2.1 GlaxoSmithKline Plc Company Information
        13.2.2 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Product Offered
        13.2.3 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 GlaxoSmithKline Plc Main Business Overview
        13.2.5 GlaxoSmithKline Plc Latest Developments
    13.3 Pfizer Inc.
        13.3.1 Pfizer Inc. Company Information
        13.3.2 Pfizer Inc. Recombinant Hepatitis B Vaccine Product Offered
        13.3.3 Pfizer Inc. Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 Pfizer Inc. Main Business Overview
        13.3.5 Pfizer Inc. Latest Developments
    13.4 Sanofi Pasteur
        13.4.1 Sanofi Pasteur Company Information
        13.4.2 Sanofi Pasteur Recombinant Hepatitis B Vaccine Product Offered
        13.4.3 Sanofi Pasteur Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 Sanofi Pasteur Main Business Overview
        13.4.5 Sanofi Pasteur Latest Developments
    13.5 CSL Limited
        13.5.1 CSL Limited Company Information
        13.5.2 CSL Limited Recombinant Hepatitis B Vaccine Product Offered
        13.5.3 CSL Limited Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 CSL Limited Main Business Overview
        13.5.5 CSL Limited Latest Developments
    13.6 Emergent Biosolutions
        13.6.1 Emergent Biosolutions Company Information
        13.6.2 Emergent Biosolutions Recombinant Hepatitis B Vaccine Product Offered
        13.6.3 Emergent Biosolutions Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Emergent Biosolutions Main Business Overview
        13.6.5 Emergent Biosolutions Latest Developments
    13.7 Serum Institute of India
        13.7.1 Serum Institute of India Company Information
        13.7.2 Serum Institute of India Recombinant Hepatitis B Vaccine Product Offered
        13.7.3 Serum Institute of India Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 Serum Institute of India Main Business Overview
        13.7.5 Serum Institute of India Latest Developments
    13.8 Johnson & Johnson
        13.8.1 Johnson & Johnson Company Information
        13.8.2 Johnson & Johnson Recombinant Hepatitis B Vaccine Product Offered
        13.8.3 Johnson & Johnson Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 Johnson & Johnson Main Business Overview
        13.8.5 Johnson & Johnson Latest Developments
    13.9 Hualan Biological Engineering
        13.9.1 Hualan Biological Engineering Company Information
        13.9.2 Hualan Biological Engineering Recombinant Hepatitis B Vaccine Product Offered
        13.9.3 Hualan Biological Engineering Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 Hualan Biological Engineering Main Business Overview
        13.9.5 Hualan Biological Engineering Latest Developments
    13.10 NCPC
        13.10.1 NCPC Company Information
        13.10.2 NCPC Recombinant Hepatitis B Vaccine Product Offered
        13.10.3 NCPC Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 NCPC Main Business Overview
        13.10.5 NCPC Latest Developments
    13.11 China National Biotec Group
        13.11.1 China National Biotec Group Company Information
        13.11.2 China National Biotec Group Recombinant Hepatitis B Vaccine Product Offered
        13.11.3 China National Biotec Group Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.11.4 China National Biotec Group Main Business Overview
        13.11.5 China National Biotec Group Latest Developments
    13.12 Dalian Hissen Bio-pharm
        13.12.1 Dalian Hissen Bio-pharm Company Information
        13.12.2 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Product Offered
        13.12.3 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.12.4 Dalian Hissen Bio-pharm Main Business Overview
        13.12.5 Dalian Hissen Bio-pharm Latest Developments
    13.13 Beijing Tiantan Biological
        13.13.1 Beijing Tiantan Biological Company Information
        13.13.2 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Product Offered
        13.13.3 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.13.4 Beijing Tiantan Biological Main Business Overview
        13.13.5 Beijing Tiantan Biological Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Recombinant Hepatitis B Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Recombinant Hepatitis B Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of 10mcg/ml
    Table 4. Major Players of 10mcg/0.5ml
    Table 5. Global Recombinant Hepatitis B Vaccine Sales by Type (2017-2022) & (K Units)
    Table 6. Global Recombinant Hepatitis B Vaccine Sales Market Share by Type (2017-2022)
    Table 7. Global Recombinant Hepatitis B Vaccine Revenue by Type (2017-2022) & ($ million)
    Table 8. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Type (2017-2022)
    Table 9. Global Recombinant Hepatitis B Vaccine Sale Price by Type (2017-2022) & (US$/Unit)
    Table 10. Global Recombinant Hepatitis B Vaccine Sales by Application (2017-2022) & (K Units)
    Table 11. Global Recombinant Hepatitis B Vaccine Sales Market Share by Application (2017-2022)
    Table 12. Global Recombinant Hepatitis B Vaccine Revenue by Application (2017-2022)
    Table 13. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Application (2017-2022)
    Table 14. Global Recombinant Hepatitis B Vaccine Sale Price by Application (2017-2022) & (US$/Unit)
    Table 15. Global Recombinant Hepatitis B Vaccine Sales by Company (2020-2022) & (K Units)
    Table 16. Global Recombinant Hepatitis B Vaccine Sales Market Share by Company (2020-2022)
    Table 17. Global Recombinant Hepatitis B Vaccine Revenue by Company (2020-2022) ($ Millions)
    Table 18. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Company (2020-2022)
    Table 19. Global Recombinant Hepatitis B Vaccine Sale Price by Company (2020-2022) & (US$/Unit)
    Table 20. Key Manufacturers Recombinant Hepatitis B Vaccine Producing Area Distribution and Sales Area
    Table 21. Players Recombinant Hepatitis B Vaccine Products Offered
    Table 22. Recombinant Hepatitis B Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 23. New Products and Potential Entrants
    Table 24. Mergers & Acquisitions, Expansion
    Table 25. Global Recombinant Hepatitis B Vaccine Sales by Geographic Region (2017-2022) & (K Units)
    Table 26. Global Recombinant Hepatitis B Vaccine Sales Market Share Geographic Region (2017-2022)
    Table 27. Global Recombinant Hepatitis B Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 28. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Geographic Region (2017-2022)
    Table 29. Global Recombinant Hepatitis B Vaccine Sales by Country/Region (2017-2022) & (K Units)
    Table 30. Global Recombinant Hepatitis B Vaccine Sales Market Share by Country/Region (2017-2022)
    Table 31. Global Recombinant Hepatitis B Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
    Table 32. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Country/Region (2017-2022)
    Table 33. Americas Recombinant Hepatitis B Vaccine Sales by Country (2017-2022) & (K Units)
    Table 34. Americas Recombinant Hepatitis B Vaccine Sales Market Share by Country (2017-2022)
    Table 35. Americas Recombinant Hepatitis B Vaccine Revenue by Country (2017-2022) & ($ Millions)
    Table 36. Americas Recombinant Hepatitis B Vaccine Revenue Market Share by Country (2017-2022)
    Table 37. Americas Recombinant Hepatitis B Vaccine Sales by Type (2017-2022) & (K Units)
    Table 38. Americas Recombinant Hepatitis B Vaccine Sales Market Share by Type (2017-2022)
    Table 39. Americas Recombinant Hepatitis B Vaccine Sales by Application (2017-2022) & (K Units)
    Table 40. Americas Recombinant Hepatitis B Vaccine Sales Market Share by Application (2017-2022)
    Table 41. APAC Recombinant Hepatitis B Vaccine Sales by Region (2017-2022) & (K Units)
    Table 42. APAC Recombinant Hepatitis B Vaccine Sales Market Share by Region (2017-2022)
    Table 43. APAC Recombinant Hepatitis B Vaccine Revenue by Region (2017-2022) & ($ Millions)
    Table 44. APAC Recombinant Hepatitis B Vaccine Revenue Market Share by Region (2017-2022)
    Table 45. APAC Recombinant Hepatitis B Vaccine Sales by Type (2017-2022) & (K Units)
    Table 46. APAC Recombinant Hepatitis B Vaccine Sales Market Share by Type (2017-2022)
    Table 47. APAC Recombinant Hepatitis B Vaccine Sales by Application (2017-2022) & (K Units)
    Table 48. APAC Recombinant Hepatitis B Vaccine Sales Market Share by Application (2017-2022)
    Table 49. Europe Recombinant Hepatitis B Vaccine Sales by Country (2017-2022) & (K Units)
    Table 50. Europe Recombinant Hepatitis B Vaccine Sales Market Share by Country (2017-2022)
    Table 51. Europe Recombinant Hepatitis B Vaccine Revenue by Country (2017-2022) & ($ Millions)
    Table 52. Europe Recombinant Hepatitis B Vaccine Revenue Market Share by Country (2017-2022)
    Table 53. Europe Recombinant Hepatitis B Vaccine Sales by Type (2017-2022) & (K Units)
    Table 54. Europe Recombinant Hepatitis B Vaccine Sales Market Share by Type (2017-2022)
    Table 55. Europe Recombinant Hepatitis B Vaccine Sales by Application (2017-2022) & (K Units)
    Table 56. Europe Recombinant Hepatitis B Vaccine Sales Market Share by Application (2017-2022)
    Table 57. Middle East & Africa Recombinant Hepatitis B Vaccine Sales by Country (2017-2022) & (K Units)
    Table 58. Middle East & Africa Recombinant Hepatitis B Vaccine Sales Market Share by Country (2017-2022)
    Table 59. Middle East & Africa Recombinant Hepatitis B Vaccine Revenue by Country (2017-2022) & ($ Millions)
    Table 60. Middle East & Africa Recombinant Hepatitis B Vaccine Revenue Market Share by Country (2017-2022)
    Table 61. Middle East & Africa Recombinant Hepatitis B Vaccine Sales by Type (2017-2022) & (K Units)
    Table 62. Middle East & Africa Recombinant Hepatitis B Vaccine Sales Market Share by Type (2017-2022)
    Table 63. Middle East & Africa Recombinant Hepatitis B Vaccine Sales by Application (2017-2022) & (K Units)
    Table 64. Middle East & Africa Recombinant Hepatitis B Vaccine Sales Market Share by Application (2017-2022)
    Table 65. Key Market Drivers & Growth Opportunities of Recombinant Hepatitis B Vaccine
    Table 66. Key Market Challenges & Risks of Recombinant Hepatitis B Vaccine
    Table 67. Key Industry Trends of Recombinant Hepatitis B Vaccine
    Table 68. Recombinant Hepatitis B Vaccine Raw Material
    Table 69. Key Suppliers of Raw Materials
    Table 70. Recombinant Hepatitis B Vaccine Distributors List
    Table 71. Recombinant Hepatitis B Vaccine Customer List
    Table 72. Global Recombinant Hepatitis B Vaccine Sales Forecast by Region (2023-2028) & (K Units)
    Table 73. Global Recombinant Hepatitis B Vaccine Sales Market Forecast by Region
    Table 74. Global Recombinant Hepatitis B Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 75. Global Recombinant Hepatitis B Vaccine Revenue Market Share Forecast by Region (2023-2028)
    Table 76. Americas Recombinant Hepatitis B Vaccine Sales Forecast by Country (2023-2028) & (K Units)
    Table 77. Americas Recombinant Hepatitis B Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 78. APAC Recombinant Hepatitis B Vaccine Sales Forecast by Region (2023-2028) & (K Units)
    Table 79. APAC Recombinant Hepatitis B Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 80. Europe Recombinant Hepatitis B Vaccine Sales Forecast by Country (2023-2028) & (K Units)
    Table 81. Europe Recombinant Hepatitis B Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 82. Middle East & Africa Recombinant Hepatitis B Vaccine Sales Forecast by Country (2023-2028) & (K Units)
    Table 83. Middle East & Africa Recombinant Hepatitis B Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 84. Global Recombinant Hepatitis B Vaccine Sales Forecast by Type (2023-2028) & (K Units)
    Table 85. Global Recombinant Hepatitis B Vaccine Sales Market Share Forecast by Type (2023-2028)
    Table 86. Global Recombinant Hepatitis B Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 87. Global Recombinant Hepatitis B Vaccine Revenue Market Share Forecast by Type (2023-2028)
    Table 88. Global Recombinant Hepatitis B Vaccine Sales Forecast by Application (2023-2028) & (K Units)
    Table 89. Global Recombinant Hepatitis B Vaccine Sales Market Share Forecast by Application (2023-2028)
    Table 90. Global Recombinant Hepatitis B Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 91. Global Recombinant Hepatitis B Vaccine Revenue Market Share Forecast by Application (2023-2028)
    Table 92. Merck Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 93. Merck Recombinant Hepatitis B Vaccine Product Offered
    Table 94. Merck Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 95. Merck Main Business
    Table 96. Merck Latest Developments
    Table 97. GlaxoSmithKline Plc Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 98. GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Product Offered
    Table 99. GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 100. GlaxoSmithKline Plc Main Business
    Table 101. GlaxoSmithKline Plc Latest Developments
    Table 102. Pfizer Inc. Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 103. Pfizer Inc. Recombinant Hepatitis B Vaccine Product Offered
    Table 104. Pfizer Inc. Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 105. Pfizer Inc. Main Business
    Table 106. Pfizer Inc. Latest Developments
    Table 107. Sanofi Pasteur Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 108. Sanofi Pasteur Recombinant Hepatitis B Vaccine Product Offered
    Table 109. Sanofi Pasteur Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 110. Sanofi Pasteur Main Business
    Table 111. Sanofi Pasteur Latest Developments
    Table 112. CSL Limited Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 113. CSL Limited Recombinant Hepatitis B Vaccine Product Offered
    Table 114. CSL Limited Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 115. CSL Limited Main Business
    Table 116. CSL Limited Latest Developments
    Table 117. Emergent Biosolutions Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 118. Emergent Biosolutions Recombinant Hepatitis B Vaccine Product Offered
    Table 119. Emergent Biosolutions Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 120. Emergent Biosolutions Main Business
    Table 121. Emergent Biosolutions Latest Developments
    Table 122. Serum Institute of India Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 123. Serum Institute of India Recombinant Hepatitis B Vaccine Product Offered
    Table 124. Serum Institute of India Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 125. Serum Institute of India Main Business
    Table 126. Serum Institute of India Latest Developments
    Table 127. Johnson & Johnson Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 128. Johnson & Johnson Recombinant Hepatitis B Vaccine Product Offered
    Table 129. Johnson & Johnson Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 130. Johnson & Johnson Main Business
    Table 131. Johnson & Johnson Latest Developments
    Table 132. Hualan Biological Engineering Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 133. Hualan Biological Engineering Recombinant Hepatitis B Vaccine Product Offered
    Table 134. Hualan Biological Engineering Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 135. Hualan Biological Engineering Main Business
    Table 136. Hualan Biological Engineering Latest Developments
    Table 137. NCPC Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 138. NCPC Recombinant Hepatitis B Vaccine Product Offered
    Table 139. NCPC Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 140. NCPC Main Business
    Table 141. NCPC Latest Developments
    Table 142. China National Biotec Group Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 143. China National Biotec Group Recombinant Hepatitis B Vaccine Product Offered
    Table 144. China National Biotec Group Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 145. China National Biotec Group Main Business
    Table 146. China National Biotec Group Latest Developments
    Table 147. Dalian Hissen Bio-pharm Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 148. Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Product Offered
    Table 149. Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 150. Dalian Hissen Bio-pharm Main Business
    Table 151. Dalian Hissen Bio-pharm Latest Developments
    Table 152. Beijing Tiantan Biological Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 153. Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Product Offered
    Table 154. Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 155. Beijing Tiantan Biological Main Business
    Table 156. Beijing Tiantan Biological Latest Developments
List of Figures
    Figure 1. Picture of Recombinant Hepatitis B Vaccine
    Figure 2. Recombinant Hepatitis B Vaccine Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Recombinant Hepatitis B Vaccine Sales Growth Rate 2017-2028 (K Units)
    Figure 7. Global Recombinant Hepatitis B Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Recombinant Hepatitis B Vaccine Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of 10mcg/ml
    Figure 10. Product Picture of 10mcg/0.5ml
    Figure 11. Global Recombinant Hepatitis B Vaccine Sales Market Share by Type in 2021
    Figure 12. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Type (2017-2022)
    Figure 13. Recombinant Hepatitis B Vaccine Consumed in Newborn
    Figure 14. Global Recombinant Hepatitis B Vaccine Market: Newborn (2017-2022) & (K Units)
    Figure 15. Recombinant Hepatitis B Vaccine Consumed in Primary School Students
    Figure 16. Global Recombinant Hepatitis B Vaccine Market: Primary School Students (2017-2022) & (K Units)
    Figure 17. Recombinant Hepatitis B Vaccine Consumed in Adult
    Figure 18. Global Recombinant Hepatitis B Vaccine Market: Adult (2017-2022) & (K Units)
    Figure 19. Global Recombinant Hepatitis B Vaccine Sales Market Share by Application (2017-2022)
    Figure 20. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Application in 2021
    Figure 21. Recombinant Hepatitis B Vaccine Revenue Market by Company in 2021 ($ Million)
    Figure 22. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Company in 2021
    Figure 23. Global Recombinant Hepatitis B Vaccine Sales Market Share by Geographic Region (2017-2022)
    Figure 24. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Geographic Region in 2021
    Figure 25. Global Recombinant Hepatitis B Vaccine Sales Market Share by Region (2017-2022)
    Figure 26. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Country/Region in 2021
    Figure 27. Americas Recombinant Hepatitis B Vaccine Sales 2017-2022 (K Units)
    Figure 28. Americas Recombinant Hepatitis B Vaccine Revenue 2017-2022 ($ Millions)
    Figure 29. APAC Recombinant Hepatitis B Vaccine Sales 2017-2022 (K Units)
    Figure 30. APAC Recombinant Hepatitis B Vaccine Revenue 2017-2022 ($ Millions)
    Figure 31. Europe Recombinant Hepatitis B Vaccine Sales 2017-2022 (K Units)
    Figure 32. Europe Recombinant Hepatitis B Vaccine Revenue 2017-2022 ($ Millions)
    Figure 33. Middle East & Africa Recombinant Hepatitis B Vaccine Sales 2017-2022 (K Units)
    Figure 34. Middle East & Africa Recombinant Hepatitis B Vaccine Revenue 2017-2022 ($ Millions)
    Figure 35. Americas Recombinant Hepatitis B Vaccine Sales Market Share by Country in 2021
    Figure 36. Americas Recombinant Hepatitis B Vaccine Revenue Market Share by Country in 2021
    Figure 37. United States Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 38. Canada Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 39. Mexico Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 40. Brazil Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 41. APAC Recombinant Hepatitis B Vaccine Sales Market Share by Region in 2021
    Figure 42. APAC Recombinant Hepatitis B Vaccine Revenue Market Share by Regions in 2021
    Figure 43. China Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 44. Japan Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 45. South Korea Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 46. Southeast Asia Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 47. India Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 48. Australia Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 49. Europe Recombinant Hepatitis B Vaccine Sales Market Share by Country in 2021
    Figure 50. Europe Recombinant Hepatitis B Vaccine Revenue Market Share by Country in 2021
    Figure 51. Germany Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 52. France Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 53. UK Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 54. Italy Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 55. Russia Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 56. Middle East & Africa Recombinant Hepatitis B Vaccine Sales Market Share by Country in 2021
    Figure 57. Middle East & Africa Recombinant Hepatitis B Vaccine Revenue Market Share by Country in 2021
    Figure 58. Egypt Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 59. South Africa Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 60. Israel Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 61. Turkey Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 62. GCC Country Recombinant Hepatitis B Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 63. Manufacturing Cost Structure Analysis of Recombinant Hepatitis B Vaccine in 2021
    Figure 64. Manufacturing Process Analysis of Recombinant Hepatitis B Vaccine
    Figure 65. Industry Chain Structure of Recombinant Hepatitis B Vaccine
    Figure 66. Channels of Distribution
    Figure 67. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Recombinant Hepatitis B Vaccine Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Recombinant Hepatitis B Vaccine Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Recombinant Hepatitis B Vaccine Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports